A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

Vanda Pharmaceuticals has paused the clinical program for VQW-765 after a phase 3 trial evaluating the drug for social anxiety disorder failed to show significant distress reduction compared with ...

Michelle Min, MD, MS, met with the MPR team to discuss multidisciplinary collaboration in the treatment of cutaneous lupus, as well as the current standard of care and emerging therapies on the ...

Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

HealthDay News — Updated recommendations are presented for the management of urinary tract infections (UTIs) in infants and children younger than 5 years in a clinical practice guideline (CPG) issued ...

Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...

Risk for ischemic stroke, myocardial infarction were increased with prolonged use with doses >1 mg/day for more than one year ...

Dr Ablon discusses important key points providers should keep in mind during their evaluations of patients seeking aesthetic ...

Guidelines present first-, second-, and third-line treatments and emphasize use of an informed decision-making approach ...

Protein (sodium and calcium caseinates, L-arginine), carbohydrate (corn syrup, fructose), fat (high oleic sunflower, MCT, corn oils), L-carnitine, taurine, vitamins ...